| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.97 |
| Statins |
0 |
0.73 |
| Dementia |
0 |
0.58 |
| Cognition |
0 |
0.3 |
| Heart Failure (HF) |
0 |
0.14 |
| Hypertension |
0 |
0.13 |
| Mild Cognitive Impairment |
0 |
0.8 |
| Aspirin |
0 |
0.09 |
| Cognitive Impairment |
0 |
0.9 |
| Heart |
0 |
0.09 |
| Cardiovascular disease |
0 |
0.06 |
| Disability |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Memory |
0 |
0.06 |
| Memory Problems |
0 |
0.06 |
| Cancer |
0 |
0.04 |
| Geriatrics |
0 |
0.8 |
| LDL Cholesterol |
0 |
0.04 |
| Chronic Kidney Disease |
0 |
0.03 |
| Renal Cell Carcinoma |
0 |
0.03 |
| Renal Failure |
0 |
0.03 |
| Biomarker |
0 |
0.02 |
| Clinical Guidelines |
0 |
0.02 |
| Concerns of Elderly |
0 |
0.75 |
| Health Care Quality, Access, and Evaluation |
0 |
0.02 |
| Hemorrhage |
0 |
0.02 |
| Obesity |
0 |
0.02 |
| Patient History |
0 |
0.02 |
| Renal Disease |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |